Channel Robotics: Intelligence in Surgeons’ Hands

Robotic surgery has carried a limiting assumption for decades: that better tools meant bigger machines. Multi-million dollar consoles. Dedicated facilities. Large teams to set up, plan, and run each procedure. These tools are excellent but limited to the 2,500 or so largest medical centers in the world, while there are millions of patients served by an additional 200,000+ ambulatory surgery centers and community clinics capable of performing flexible endoscopic procedures.

Philip Weissbrod and Michael Yip, founders of Channel Robotics, saw that gap not as a market opportunity, but as a failure of intent. With firsthand experience in surgery as well as robotics, they're delivering a solution that utilizes the best in autonomous robotics while expanding the applicability of their inventions for every surgeon who uses endoscopes today. 

A Rare Combination

Philip is a practicing surgeon and inaugural Chair of Otolaryngology at UC San Diego. He’s someone who understands from the inside what it actually feels like to need better tools. Michael is a UC San Diego roboticist, member of the National Academy of Inventors, and one of the most published researchers in surgical robotics, with prior collaborations at the frontier of the field.

Their individual paths to this point are distinguished, and the combination of their insights brings depth and breadth together at the right time. Clinical credibility and engineering innovation brought together to solve the problem, with the shared conviction that the current model of surgical robotics is fundamentally constraining who gets access to better care.

They're not building for a hypothetical user. Philip has long been that user. And their ambition scaled with that clarity. Channel isn't pitching an incremental improvement to existing tools. They're making the case that a new architecture can emerge built for scale from the founder’s expertise and experience in their domains.

Bringing Robotics to the Other 200,000 Clinics

There's a version of the robotic surgery future that looks like science fiction: autonomous machines performing procedures while surgeons step back. The best robots won't replace surgeons. They'll make it seamless for the best surgeons to work at their best while implementing new techniques and procedures with robotic assistance, right in their hands. The skill, the judgment, the clinical instinct - that stays human. Channel Robotics delivers the precision, dexterity, and intelligence to amplify each surgeon’s best skills.

Channel Robotics approach — a handheld, AI-enhanced robotic instrument that clips onto equipment already in the room — makes that kind of assistance accessible far beyond large clinics that have historically been the only buyers. Designed from inception to change the addressable footprint of surgical robotics, Channel’s entry points in the market are clear and high-need 75 million people worldwide are beneficiaries of flexible endoscopy procedures in GI, pulmonary, urology, and beyond.

A Long-Term Bet

True tends to invest when an idea feels authentic in the hands of the founders, and has the potential to change markets, not just fit into them. Both are true here.

The longer vision for Channel Robotics is what excites us most: a platform where intelligence, robotics, and surgery come together as a tool available to skilled clinicians wherever they practice. That's a meaningful shift in who gets access to the best care, and it starts with getting the technology right, in the right hands.

We're honored to be part of Philip and Michael's journey. More on the company's Seed+ financing round, led by True Ventures, here.